Detalles de la búsqueda
1.
An Analysis of 20 Cases of Radiation-Associated Sarcoma, Including 4 Cases Treated by Carbon Ion Radiotherapy.
Oncology
; 100(3): 148-154, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34915507
2.
Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Jpn J Clin Oncol
; 52(12): 1430-1435, 2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36093731
3.
Predictive factors of late biochemical recurrence after radical prostatectomy.
Jpn J Clin Oncol
; 47(3): 233-238, 2017 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27940489
4.
Biochemical failure after radical prostatectomy in intermediate-risk group men increases with the number of risk factors.
Indian J Urol
; 33(1): 64-69, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28197033
5.
Change in the Neutrophil-to-Eosinophil Ratio After Avelumab Maintenance for Advanced Urothelial Carcinoma: The UROKYU Study.
Anticancer Res
; 44(4): 1675-1681, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537962
6.
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study.
Curr Oncol
; 31(2): 862-871, 2024 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38392058
7.
A Case of Cystic Retroperitoneal Dedifferentiated Liposarcoma Diagnosed by Percutaneous Image-Guided Biopsy.
Case Rep Oncol
; 16(1): 1460-1465, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38028568
8.
Organ-specific Tumor Response to Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma: A Multicenter Retrospective Study.
Anticancer Res
; 43(12): 5689-5698, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38030199
9.
Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study.
Anticancer Res
; 43(10): 4701-4708, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772560
10.
Cutaneous ureterostomy using the transverse mesocolon.
Int J Urol
; 19(2): 174-6, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22093086
11.
Change of genitourinary cancer patients' perception and expectations over the course of pharmacotherapy.
PLoS One
; 17(11): e0278039, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36413565
12.
Cytoreductive Nephrectomy After Combination of Nivolumab Plus Ipilimumab for Mucinous Tubular and Spindle Cell Carcinoma of the Kidney With Bone Metastases: A Case Report.
In Vivo
; 36(1): 510-521, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34972756
13.
Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study.
Anticancer Res
; 42(3): 1571-1577, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35220254
14.
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab.
Cancer Manag Res
; 14: 1641-1651, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35535266
15.
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study.
Clin Genitourin Cancer
; 20(5): 499.e1-499.e8, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35624001
16.
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status.
Onco Targets Ther
; 15: 1321-1330, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36388155
17.
Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma.
Mol Clin Oncol
; 14(5): 91, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767860
18.
Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
In Vivo
; 35(5): 2869-2874, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34410980
19.
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab.
Cancer Manag Res
; 13: 8049-8056, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34729023
20.
Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy.
Onco Targets Ther
; 14: 1981-1988, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33776447